stars 1 stars 2 stars 3

InsideTx streamlines RNA-LNP formulation from screening to manufacturing. Founded at the intersection of microfluidics and biotechnology, we build formulation platforms that cover the full RNA-LNP & nanomedicine development pipeline — so researchers can focus on the science, not the process. TAMARA is our all-in-one R&D platform for nanoparticle formulation. It handles everything from early screening to preclinical in-vivo studies in a single instrument (0.2–30 mL), with zero formulation losses, reusable microfluidic chips, and two mixing geometries on one reversible chip. As one of our users put it: "I'm absolutely blown away by how user-friendly, efficient, and straightforward this system is!" NanoPulse addresses what comes next: scale-up. Built on a proprietary mixing technology, it is the only platform that ensures identical nanoparticles at every scale — from microliters to tens of liters. Same mixing, same particle characteristics, from bench to GMP production. No re-optimization between scales saving precious time and improves chances of success. We also offer formulation services (CRO) and hands-on RNA-LNP training, giving teams without in-house expertise a direct path into LNP development. TAMARA and NanoPulse are compatible with mRNA-LNP, siRNA-LNP, saRNA-LNP, CRISPR, liposomes, PLGA, SLNs, polymer and peptide nanoparticles, and more.

Inside Tx Questions

Thomas Guerinier is the CEO of Inside Tx.

13 people are employed at Inside Tx.

Top Inside Tx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users